Mettis Global News
Mettis Global News
Mettis Global News
Mettis Global News

Trending :

BF Biosciences launches human insulin ‘Ferulin’

BF Biosciences inks deal with Lucky Core
Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

August 15, 2024 (MLN): BF Biosciences Limited, a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ) has successfully launched human insulin under the brand name "Ferulin", the company's filing on PSX revealed.

This launch marks a significant milestone in our commitment to STOP DIABETES, expand our product portfolio and enhance the availability of life-saving medicines in the market.

Ferulin has been developed with the highest quality standards and is intended to provide effective and affordable diabetes treatment to patients across Pakistan.

Being the 1st Biotech Plant in Pakistan, BF Biosciences Limited has been committed to the production of essential medicines for the treatment of HCV, Cancer, Cardiology and other therapeutic areas for over a decade.

The company is confident that Ferulin will positively impact the subsidiary's growth and will further strengthen its mission to address unmet patient needs.

Copyright Mettis Link News

Posted on: 2024-08-15T11:11:43+05:00